Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction

Cardiovascular Research

Volumn 100, Issue 2, 2013, Pages 192-200

  Fortunato, Orazio ^a   Spinetti, Gaia ^a   Specchia, Claudia ^b   Cangiano, Elisa ^c   Valgimigli, Marco ^c   Madeddu, Paolo ^d  

^a IRCCS MULTIMEDICA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Acute myocardial infarction; Circulating progenitor cells; Migration; SDF 1

Indexed keywords

STROMAL CELL DERIVED FACTOR 1;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD ANALYSIS; CELL ASSAY; CELL COUNT; CELL MIGRATION; CELL MOTILITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; FORAGE; HEART FAILURE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; ST SEGMENT ELEVATION; STEM CELL;

ACUTE MYOCARDIAL INFARCTION; CIRCULATING PROGENITOR CELLS; MIGRATION; SDF-1Α;

AGED; CELL MOVEMENT; CHEMOKINE CXCL12; CREATINE KINASE, MB FORM; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; STEM CELLS;

EID: 84886070256     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt153     Document Type: Article

References (43)

1. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-1565.
2. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP et al. Cardiac-specific troponin i levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-1349.
3. Zimmerman J, Fromm R, Meyer D, Boudreaux A, Wun CC, Smalling R et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999;99: 1671-1677.
4. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-1021.
5. Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med (Berl) 2004;82:671-677.
6. Bartunek J, Vanderheyden M, Hill J, Terzic A. Cells as biologics for cardiac repair in ischaemic heart failure. Heart 2010;96:792-800.
7. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103: 2776-2779.
8. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105:199-206.
9. Kucia M, Reca R, Jala VR, Dawn B, Ratajczak J, Ratajczak MZ. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia 2005;19: 1118-1127.
10. +-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003;108:2070-2073.
11. Mackie AR, Losordo DW. CD34-positive stem cells in the treatment of heart and vascular disease in human beings. Tex Heart Inst J 2011;38:474-485.
12. Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P et al. Intracoronary injection of CD133-positive enriched bone marrowprogenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005;112:I178-I183.
13. + progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res 2009;104:1095-1102.
14. Seeger FH, Rasper T, Koyanagi M, Fox H, Zeiher AM, Dimmeler S. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia. Arterioscler Thromb Vasc Biol 2009;29: 1802-1809.
15. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGFcontributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-3972.
16. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-864.
17. Ratajczak MZ, Majka M, Kucia M, Drukala J, Pietrzkowski Z, Peiper S et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 2003;21: 363-371.
18. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005;23:879-894.
19. Chang LT, Yuen CM, Sun CK, Wu CJ, Sheu JJ, Chua S et al. Role of stromal cell-derived factor-1alpha, level and value of circulating interleukin-10 and endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty. Circ J 2009;73:1097-1104.
20. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007.
21. Fadini GP, Maruyama S, Ozaki T, Taguchi A, Meigs J, Dimmeler S et al. Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS One 2010;5: e11488.
22. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events. Circulation 2005;111:2981-2987.
23. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS et al. Myocardial infarction accelerates atherosclerosis. Nature 2012;487:325-329.
24. Leone AM, Rutella S, Bonanno G, Abbate A, Rebuzzi AG, Giovannini S et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005;26:1196-1204.
25. + cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996;5:213-226.
26. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845.
27. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172; discussion 207-212.
28. + progenitor cells after myocardial infarction. Eur J Clin Invest 2007;37:842-851.
29. Wojakowski W, Tendera M, Zebzda A, Michalowska A, Majka M, Kucia M et al. Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur Heart J 2006;27:283-289.
30. Tsuboi R, Sato Y, Rifkin DB. Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells. J Cell Biol 1990;110:511-517.
31. Zheng H, Fu G, Dai T, Huang H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1[alpha]/CXCR4 via PI3 K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 2007;50:274-280.
32. Rönnstrand L, Heldin C-H. Mechanisms of platelet-derived growth factor-induced chemotaxis. Int J Cancer 2001;91:757-762.
33. Marchioli R, Avanzini F, Barzi F, Chieffo C, Di Castelnuovo A, Franzosi MG et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart. Eur Heart J 2001;22: 2085-2103.
34. Kehl DW, Iqbal N, Fard A, Kipper BA, De La Parra Landa A, Maisel AS. Biomarkers in acute myocardial injury. Transl Res 2012;159:252-264.
35. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTOIIA Investigators. N Engl J Med 1996;335:1333-1341.
36. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 2005;97: 1142-1151.
37. Krankel N, Katare RG, Siragusa M, Barcelos LS, Campagnolo P, Mangialardi G et al. Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res 2008;103:1335-1343.
38. Damås JK, Wæhre T, Yndestad A, Ueland T, Müller F, Eiken HG et al. Stromal cell-derived factor-1a in unstable angina. Circulation 2002;106:36-42.
39. Saxena A, Fish JE, White MD, Yu S, Smyth JW, Shaw RM et al. Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 2008;117: 2224-2231.
40. Chen J, Chemaly E, Liang L, Kho C, Lee A, Park J et al. Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury. Am J Pathol 2010;176: 1705-1715.
41. Wei D, Wang G, Tang C, Qiu J, Zhao J, Gregersen H et al. Upregulation of SDF-1 is associated with atherosclerosis lesions induced by LDL concentration polarization. Ann Biomed Eng 2012;40:1018-1027.
42. Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 2000;86:131-138.
43. + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004;110:3213-3220.